newsfilter
← Latest News
GlobeNewswire·

Reunion Neuroscience Inc. Provides Business Update and Reports Fiscal Second Quarter 2023 Financial Results

Completed RE104 Phase 1 prespecified dose cohorts and on track to deliver interim Phase 1 analysis in the first calendar quarter of 2023.Appointed Greg Mayes as President and Chief Executive Officer, with Joseph del